Quarter Period Consolidated Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7734310

Concept 2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2016-06-01 to
2017-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
2015-06-01 to
2016-05-31
Quarter period consolidated statement of income
Statement of income
Net sales
37,984,428,000 JPY
37,787,701,000 JPY
36,370,538,000 JPY
36,229,869,000 JPY
Cost of sales
30,232,301,000 JPY
31,079,884,000 JPY
29,104,413,000 JPY
29,622,313,000 JPY
Gross profit (loss)
7,752,127,000 JPY
6,707,816,000 JPY
7,266,125,000 JPY
6,607,556,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
139,180,000 JPY
155,039,000 JPY
Bonuses
178,213,000 JPY
164,952,000 JPY
Depreciation
199,850,000 JPY
130,136,000 JPY
148,355,000 JPY
117,975,000 JPY
Selling, general and administrative expenses
3,908,893,000 JPY
3,572,828,000 JPY
3,670,937,000 JPY
3,317,279,000 JPY
Operating profit (loss)
3,832,165,000 JPY
3,123,920,000 JPY
3,555,847,000 JPY
3,250,936,000 JPY
Non-operating income
Interest income
729,000 JPY
5,111,000 JPY
718,000 JPY
6,988,000 JPY
Dividend income
66,462,000 JPY
105,660,000 JPY
58,449,000 JPY
88,751,000 JPY
Non-operating income
169,270,000 JPY
156,480,000 JPY
210,229,000 JPY
219,065,000 JPY
Non-operating expenses
Interest expenses
28,565,000 JPY
26,590,000 JPY
39,565,000 JPY
35,846,000 JPY
Non-operating expenses
122,607,000 JPY
112,990,000 JPY
52,369,000 JPY
48,633,000 JPY
Ordinary profit (loss)
3,878,829,000 JPY
3,167,410,000 JPY
3,713,707,000 JPY
3,421,369,000 JPY
Extraordinary income
Extraordinary income
292,204,000 JPY
290,504,000 JPY
17,757,000 JPY
1,250,000 JPY
Extraordinary losses
Impairment losses
JPY
JPY
200,742,000 JPY
200,742,000 JPY
Extraordinary losses
285,830,000 JPY
285,814,000 JPY
305,413,000 JPY
298,803,000 JPY
Profit (loss) before income taxes
3,885,202,000 JPY
3,172,099,000 JPY
3,426,050,000 JPY
3,123,815,000 JPY
Income taxes - current
1,405,768,000 JPY
1,132,000,000 JPY
917,708,000 JPY
764,000,000 JPY
Income taxes - deferred
-147,582,000 JPY
-116,425,000 JPY
-39,010,000 JPY
-17,630,000 JPY
Income taxes
1,258,186,000 JPY
1,015,574,000 JPY
878,698,000 JPY
746,369,000 JPY
Profit (loss)
2,156,524,000 JPY
2,156,524,000 JPY
2,627,016,000 JPY
2,156,524,000 JPY
2,156,524,000 JPY
2,377,446,000 JPY
2,547,351,000 JPY
2,377,446,000 JPY
2,377,446,000 JPY
2,377,446,000 JPY
Profit attributable to
Profit (loss) attributable to non-controlling interests
-29,265,000 JPY
-19,068,000 JPY
Profit (loss) attributable to owners of parent
2,656,281,000 JPY
2,656,281,000 JPY
2,656,281,000 JPY
2,566,419,000 JPY
2,566,419,000 JPY
2,566,419,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-176,651,000 JPY
-195,482,000 JPY
Foreign currency translation adjustment
-93,458,000 JPY
-153,276,000 JPY
Remeasurements of defined benefit plans, net of tax
170,394,000 JPY
-188,007,000 JPY
Other comprehensive income
-99,714,000 JPY
-536,766,000 JPY
Comprehensive income
2,527,301,000 JPY
2,010,585,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
2,584,641,000 JPY
2,074,835,000 JPY
Comprehensive income attributable to non-controlling interests
-57,339,000 JPY
-64,250,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.